Mode of insertion of praziquantel and derivatives into lipid membranes.
We report here about the relationship between the destabilization of the lipid organization induced by praziquantel and derivatives and their mode of insertion into the lipid matrix. Measurements of lipid transition temperature and efflux of 6-carboxyfluorescein encapsulated in liposomes establish the lipid destabilizing capacity of praziquantel as compared to praziquantel derivatives. IR spectroscopy (attenuated total reflection technique) applied to oriented lipid bilayers indicates that praziquantel or derivatives do not modify significantly the lipid structure. In order to give a molecular description of the position of the drug into the lipid bilayer, we applied a conformational analysis procedure making it possible to calculate the structure of amphiphilic molecules assembled in aggregates and the mode of insertion of amphiphilic drugs into a lipid layer. The praziquantel lipid destabilizing capacity is explained in terms of the high praziquantel-lipid interaction and the large area occupied per drug molecule in the lipid layer.
Schepers
H
H
Laboratoire de Chimie-Physique des Macromolécules aux Interfaces, Université Libre de Bruxelles, Belgium.
Brasseur
R
R
Goormaghtigh
E
E
Duquenoy
P
P
Ruysschaert
J M
JM
D015060:1,2-Dipalmitoylphosphatidylcholine / Q000378:metabolism; D000818:Animals; D002152:Calorimetry, Differential Scanning; D005452:Fluoresceins; D008081:Liposomes / Q000378:metabolism; D008563:Membrane Lipids / Q000378:metabolism*; D008968:Molecular Conformation; D011223:Praziquantel / Q000378:metabolism*; D012550:Schistosoma mansoni / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D013055:Spectrophotometry, Infrared; D013816:Thermodynamics
D005452:Fluoresceins; D008081:Liposomes; D008563:Membrane Lipids; D015060:1,2-Dipalmitoylphosphatidylcholine; C024098:6-carboxyfluorescein; D011223:Praziquantel